Literature DB >> 24577817

Were you identified to be at high fracture risk by FRAX® before your osteoporotic fracture occurred?

Xiao-feng Chen1, Xiao-lin Li, Hui Zhang, Ge-jun Liu.   

Abstract

With the increasing longevity and the growing size of the aging population, China is among the developing countries with the greatest burden of osteoporotic fractures (OFs). Identification of individuals at high fracture risk to provide early treatment in developing countries with limited resources remains a challenge. Our aim was to calculate the FRAX® values in a selected mainland Chinese population the day before the occurrence of an OF and to compare the results with the Osteoporosis Foundation (NOF) thresholds. To define a population at high fracture risk, we selected patients in the orthopedic emergency cohort from Shanghai Sixth People's Hospital, China. To calculate the FRAX® the day before the actual OF, the actual fracture was not considered as a previous fracture. Subjects with a FRAX® value lower than the NOF thresholds were not considered at high risk. One-hundred ninety-eight patients were included with a mean age of 69.9 ± 10.1 years old, and 78.8 % were female. Major fracture sites included hip (41.9 %), proximal humerus (22.2 %), forearm (27.8 %), spine (6.6 %), and pelvis (1.5 %). Overall, only two (1.0 %) patients had a 10-year major fracture probability ≥20 %, and 84 (42.4 %) patients had a 10-year hip fracture probability ≥3 %. More than half of the population was not identified to be at high risk by the FRAX® BMI (body mass index). For age groups 55-59, 60-69, 70-79, and 80-90 years old, respectively, the mean FRAX® BMI values (major OF/hip fracture) were 3.5/0.7, 5.7/1.8, 8.2/4.7, and 8.6/4.8 %. Dual-energy X-ray absorptiometry was available for 58 patients, and 41.2 % had a T-score ≤ -2.5 standard deviation (lumbar spine and/or femoral neck and/or total hip). Only six (17.6 %) patients with a normal or osteopenic BMD were classified at high risk by the FRAX® BMD (bone mineral density). The NOF thresholds could only identify fewer than half of the studied population to be at high risk the day before an actual OF, and the 10-year hip fracture probability seemed to perform better than the 10-year major fracture probability. Prospective population-based studies are needed to validate the prediction of Chinese FRAX® model and to establish ideal thresholds.

Entities:  

Mesh:

Year:  2014        PMID: 24577817     DOI: 10.1007/s10067-014-2533-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

Review 1.  Assessment of fracture risk.

Authors:  John A Kanis; Frederik Borgstrom; Chris De Laet; Helena Johansson; Olof Johnell; Bengt Jonsson; Anders Oden; Niklas Zethraeus; Bruce Pfleger; Nikolai Khaltaev
Journal:  Osteoporos Int       Date:  2004-12-23       Impact factor: 4.507

2.  Optimal use of FRAX.

Authors:  Christian Roux; Thierry Thomas
Journal:  Joint Bone Spine       Date:  2008-12-16       Impact factor: 4.929

3.  Spine-hip T-score difference predicts major osteoporotic fracture risk independent of FRAX(®): a population-based report from CAMOS.

Authors:  William D Leslie; Christopher S Kovacs; Wojciech P Olszynski; Tanveer Towheed; Stephanie M Kaiser; Jerilynn C Prior; Robert G Josse; Sophie A Jamal; Nancy Kreiger; David Goltzman
Journal:  J Clin Densitom       Date:  2011-07-01       Impact factor: 2.617

4.  Fracture burden in relation to low bone mineral density and FRAX(®) probability.

Authors:  William D Leslie; Suzanne Morin
Journal:  J Clin Densitom       Date:  2011-07-01       Impact factor: 2.617

5.  Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women.

Authors:  E Y N Cheung; C H Bow; C L Cheung; C Soong; S Yeung; C Loong; A Kung
Journal:  Osteoporos Int       Date:  2011-05-12       Impact factor: 4.507

6.  Validation of the FRAX predictive model for major osteoporotic fracture in a historical cohort of Spanish women.

Authors:  Cristian Tebé Cordomí; Luís Miguel Del Río; Silvana Di Gregorio; Lidia Casas; Maria-Dolors Estrada; Anna Kotzeva; Mireia Espallargues
Journal:  J Clin Densitom       Date:  2012-06-29       Impact factor: 2.617

7.  Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility.

Authors:  W Pluskiewicz; P Adamczyk; E Franek; P Leszczynski; E Sewerynek; H Wichrowska; L Napiorkowska; T Kostyk; M Stuss; W Stepien-Klos; K S Golba; B Drozdzowska
Journal:  Bone       Date:  2010-02-13       Impact factor: 4.398

8.  Hip fractures in the elderly: a world-wide projection.

Authors:  C Cooper; G Campion; L J Melton
Journal:  Osteoporos Int       Date:  1992-11       Impact factor: 4.507

9.  BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

Authors:  Katie L Stone; Dana G Seeley; Li-Yung Lui; Jane A Cauley; Kristine Ensrud; Warren S Browner; Michael C Nevitt; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

10.  Bone mineral density enhances use of clinical risk factors in predicting ten-year risk of osteoporotic fractures in Chinese men: the Hong Kong Osteoporosis Study.

Authors:  C H Bow; S W Y Tsang; C H N Loong; C S S Soong; S C Yeung; A W C Kung
Journal:  Osteoporos Int       Date:  2011-01-14       Impact factor: 4.507

View more
  4 in total

1.  Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.

Authors:  L Si; T M Winzenberg; Q Jiang; A J Palmer
Journal:  Osteoporos Int       Date:  2015-01-08       Impact factor: 4.507

2.  Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model.

Authors:  Shu-Ying Liu; Meng Huang; Rong Chen; Na Ding; Hong Liu; Zhong-Jian Xie; Zhi-Feng Sheng; Bi-Hua Luo; Yang-Na Ou
Journal:  Endocrine       Date:  2019-05-20       Impact factor: 3.633

3.  A non-invasive prevention program model for the assessment of osteoporosis in the early postmenopausal period: a pilot study on FRAX(®) and QUS tools advantages.

Authors:  P Villa; A P Lassandro; M C Moruzzi; I D Amar; L Vacca; F Di Nardo; C De Waure; A Pontecorvi; G Scambia
Journal:  J Endocrinol Invest       Date:  2015-07-04       Impact factor: 4.256

4.  Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study.

Authors:  L Si; T M Winzenberg; M Chen; Q Jiang; A Neil; A J Palmer
Journal:  Osteoporos Int       Date:  2016-01-27       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.